scholarly article | Q13442814 |
P50 | author | Andrew Kenneth Burroughs | Q18385218 |
Dimitrios P. Bogdanos | Q48362185 | ||
P2093 | author name string | Daniel S Smyk | |
Eirini I Rigopoulou | |||
Maria G Mytilinaiou | |||
Cristina Rigamonti | |||
P2860 | cites work | Rheumatic disorders in primary biliary cirrhosis | Q24514482 |
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants | Q24633806 | ||
[Association of extrahepatic autoimmune diseases in primary biliary cirrhosis--clinical statistics and analyses of Japanese and non-Japanese cases] | Q77490583 | ||
Bosentan therapy for pulmonary arterial hypertension | Q77801473 | ||
Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited scleroderma | Q77807929 | ||
Systemic scleroderma, A clinical study of 727 cases | Q79087145 | ||
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? | Q79871772 | ||
Origin of cross-reactive autoimmunity in primary biliary cirrhosis | Q79910285 | ||
HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study | Q80188338 | ||
Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience | Q80788168 | ||
Primary biliary cirrhosis | Q81246142 | ||
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis | Q81402950 | ||
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis | Q84227289 | ||
Primary biliary cirrhosis | Q84230884 | ||
Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis | Q84234141 | ||
Association of STAT4 polymorphism with systemic sclerosis in a Japanese population | Q84236673 | ||
Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history | Q93573634 | ||
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases | Q24679388 | ||
The peculiar autoimmunity of primary biliary cirrhosis | Q28144212 | ||
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis | Q28259544 | ||
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis | Q28290430 | ||
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis | Q28943317 | ||
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis | Q29417041 | ||
Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. | Q31027142 | ||
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies | Q33553751 | ||
Anticentromere antibody in primary biliary cirrhosis | Q33553886 | ||
Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region | Q33596407 | ||
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations | Q33653276 | ||
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis | Q33745849 | ||
Autoimmunity and environment: am I at risk? | Q33825348 | ||
Primary biliary cirrhosis once rare, now common in the United Kingdom? | Q33869156 | ||
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients | Q33912324 | ||
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis | Q33955502 | ||
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. | Q33965981 | ||
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls | Q34046875 | ||
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis | Q34081935 | ||
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis | Q34087671 | ||
Primary biliary cirrhosis: a 2010 update | Q34106999 | ||
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? | Q34190802 | ||
Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. | Q34328076 | ||
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines | Q34385555 | ||
Antinuclear antibodies in primary biliary cirrhosis | Q34448645 | ||
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients | Q34462959 | ||
Bacteriuria and primary biliary cirrhosis | Q34525085 | ||
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity | Q34567100 | ||
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis | Q34594429 | ||
Pathogenesis of primary biliary cirrhosis | Q34653850 | ||
Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. | Q50987542 | ||
Mortality in systemic sclerosis: a comparison with the general population. | Q51037502 | ||
Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. | Q51108387 | ||
Risk factors for primary biliary cirrhosis in a cohort of patients from the united states | Q44933098 | ||
Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations | Q45010914 | ||
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. | Q45129507 | ||
Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years | Q45161999 | ||
Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. | Q45261791 | ||
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. | Q46098794 | ||
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis | Q46408092 | ||
Clinical and serological heterogeneity in patients with anticentromere antibodies. | Q46632886 | ||
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment | Q46795010 | ||
Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population | Q47696929 | ||
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. | Q47751089 | ||
The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases | Q48109102 | ||
Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls | Q49051672 | ||
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. | Q51137626 | ||
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis | Q51586165 | ||
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. | Q51768945 | ||
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. | Q53711274 | ||
Scleroderma | Q54165664 | ||
Association of HLA class II genes with systemic sclerosis in Spanish patients. | Q54456368 | ||
Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. | Q54467810 | ||
Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. | Q55044287 | ||
EASL Clinical Practice Guidelines: management of cholestatic liver diseases. | Q55051951 | ||
Scleroderma and primary biliary cirrhosis | Q56008640 | ||
Polyautoimmunity and familial autoimmunity in systemic sclerosis | Q56452712 | ||
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database | Q56974596 | ||
Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the Molecule | Q57062000 | ||
Association between theIRF5rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis | Q57613023 | ||
BANK1is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects withIRF5andSTAT4 | Q57613025 | ||
STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosis | Q57613049 | ||
Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosis | Q58865472 | ||
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis | Q59384457 | ||
Anti-Centromere Antibody and CREST Syndrome in Patients with Primary Biliary Cirrhosis | Q67468697 | ||
A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodies | Q67939351 | ||
High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies | Q67979771 | ||
[Primary biliary cirrhosis and scleroderma] | Q68529722 | ||
Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study | Q68801707 | ||
The Presentation and Diagnosis of 100 Patients with Primary Biliary Cirrhosis | Q69302463 | ||
[Primary biliary cirrhosis and scleroderma: long-term benign course of a complex autoimmune disease] | Q70093262 | ||
Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants | Q70240365 | ||
The anticentromere antibody: disease specificity and clinical significance | Q70383558 | ||
Anticentromere antibodies in primary biliary cirrhosis | Q70440116 | ||
Primary biliary cirrhosis associated with scleroderma | Q70449670 | ||
Anticentromere antibody and primary pulmonary hypertension | Q71446708 | ||
The Association of Primary Biliary Cirrhosis and Systemic Sclerosis is not Accounted for by Cross Reactivity Between Mitochondrial and Centromere Antigens | Q71647778 | ||
Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome | Q71781429 | ||
Autoimmune associations in primary biliary cirrhosis | Q71859621 | ||
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years | Q72727069 | ||
Anticentromere antibodies (ACA): clinical distribution and disease specificity | Q72792454 | ||
Positive markers in AMA-negative PBC | Q73012261 | ||
Detection of Helicobacter in the liver of patients with chronic cholestatic liver diseases | Q73494945 | ||
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver | Q73715566 | ||
Primary biliary cirrhosis | Q73732260 | ||
Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis | Q73825688 | ||
Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone | Q74576861 | ||
[Coincidence of scleroderma and primary biliary cirrhosis. Results of a systematic study of a dermatologic patient sample] | Q74710284 | ||
Unusual suspects in primary biliary cirrhosis | Q75369505 | ||
CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMA | Q76677074 | ||
[Reynolds syndrome: the combination of scleroderma and primary biliary cirrhosis. Case report] | Q77072146 | ||
Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone | Q77483123 | ||
Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis | Q35084903 | ||
Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease | Q35359468 | ||
Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients | Q35549891 | ||
Hepatic manifestations of autoimmune rheumatic diseases | Q35553844 | ||
Antimitochondrial and other autoantibodies | Q35573899 | ||
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort | Q35596580 | ||
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis | Q35760198 | ||
Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis | Q35851191 | ||
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis | Q36495172 | ||
Is there a relation between Chlamydia infection and primary biliary cirrhosis? | Q36792963 | ||
The causes of primary biliary cirrhosis: Convenient and inconvenient truths | Q37039889 | ||
Bacteria and primary biliary cirrhosis. | Q37170862 | ||
Systemic sclerosis and infections | Q37244868 | ||
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research | Q37310658 | ||
PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. | Q37328942 | ||
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). | Q37369608 | ||
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis | Q37388003 | ||
Primary biliary cirrhosis: paradigm or paradox for autoimmunity | Q37637964 | ||
The genetics of scleroderma (systemic sclerosis). | Q37678890 | ||
Do infections facilitate the emergence of systemic sclerosis? | Q37791690 | ||
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group | Q37809920 | ||
Disease-specific autoantibodies in primary biliary cirrhosis. | Q37824020 | ||
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. | Q37836241 | ||
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? | Q37867201 | ||
Vascular impairment in patients with primary biliary cirrhosis. | Q39422924 | ||
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) | Q39473931 | ||
Autoantibodies in systemic sclerosis | Q39726030 | ||
Anticentromere antibody--clinical associations. A study of 44 patients | Q40435776 | ||
Epidemiology and natural history of primary biliary cirrhosis in a US community | Q40735092 | ||
Natural history of early primary biliary cirrhosis | Q41234807 | ||
Nuclear envelope protein autoantibodies in primary biliary cirrhosis | Q41412977 | ||
Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies | Q41605342 | ||
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians | Q41886328 | ||
Symptom development and prognosis in primary biliary cirrhosis: a study in two centers | Q41955973 | ||
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies | Q42603143 | ||
The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9year follow-up | Q42923603 | ||
Susceptibility to thyroid disorders in hepatitis C. | Q42993073 | ||
Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis | Q43419797 | ||
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid | Q43483632 | ||
Reynolds syndrome--a rare combination of 2 autoimmune diseases | Q43878632 | ||
Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease | Q44364574 | ||
Is prevalence of PBC underestimated in patients with systemic sclerosis? | Q44765533 | ||
Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis | Q44809199 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | primary biliary cholangitis | Q1072420 |
P304 | page(s) | 976427 | |
P577 | publication date | 2011-12-06 | |
P1433 | published in | International journal of rheumatology | Q26853833 |
P1476 | title | Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges | |
P478 | volume | 2011 |
Q26741006 | Capillaroscopy - a role in modern rheumatology |
Q92003565 | From pruritus to CREST syndrome in a middle aged woman |
Q90601482 | Gastrointestinal Manifestations of Systemic Sclerosis |
Q26796362 | Genetics of systemic sclerosis: recent advances |
Q38063171 | Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New? |
Q36369284 | Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence? |
Q36014535 | Sex differences associated with primary biliary cirrhosis. |
Q36361121 | TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis |
Q59130562 | The Geoepidemiology of Autoimmune Liver Disease |
Q56378345 | The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator? |
Q36417949 | Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature |
Search more.